Subcutaneous implants having limited initial release of the active principle and subsequent linearly varying extended release thereof

Details for Australian Patent Application No. 2004251457 (hide)

Owner Mediolanum Pharmaceuticals Ltd.

Inventors Mauriac, Patrice; Marion, Pierre

Agent Fisher Adams Kelly

Pub. Number AU-B-2004251457

PCT Pub. Number WO2005/000278

Priority MI2003A001303 26.06.03 IT; MI2003A001301 26.06.03 IT; MI2003A001300 26.06.03 IT; MI2003A001299 26.06.03 IT

Filing date 24 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 23 September 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/765 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/000278 Priority application(s): WO2005/000278

23 September 2010 Application Accepted

  Published as AU-B-2004251457

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251462-Method for identification of Tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof

2004251456-Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a PLGA matrix